Pleural empyema medical therapy: Difference between revisions
Prince Djan (talk | contribs) |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The mainstay of therapy for empyema includes:<ref name="pmid27815709">{{cite journal| author=Reichert M, Hecker M, Witte B, Bodner J, Padberg W, Weigand MA et al.| title=Stage-directed therapy of pleural empyema. | journal=Langenbecks Arch Surg | year= 2016 | volume= | issue= | pages= | pmid=27815709 | doi=10.1007/s00423-016-1498-9 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27815709 }}</ref> controlling the infectious focus, drainage of fluid and pus, re-expansion of the lung. This involes the use of antimicrobial agents, thrombolytics,<ref name="pmid27866276">{{cite journal| author=Porcel JM, Valencia H, Bielsa S| title=Manual Intrapleural Saline Flushing Plus Urokinase: A Potentially Useful Therapy for Complicated Parapneumonic Effusions and Empyemas. | journal=Lung | year= 2016 | volume= | issue= | pages= | pmid=27866276 | doi=10.1007/s00408-016-9964-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27866276 }}</ref><ref name="pmid21830966">{{cite journal| author=Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C et al.| title=Intrapleural use of tissue plasminogen activator and DNase in pleural infection. | journal=N Engl J Med | year= 2011 | volume= 365 | issue= 6 | pages= 518-26 | pmid=21830966 | doi=10.1056/NEJMoa1012740 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21830966 }} [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22184710 Review in: Ann Intern Med. 2011 Dec 20;155(12):JC6-9]</ref> and drainage of the pleural space.<ref name="pmid2019172">{{cite journal| author=Ashbaugh DG| title=Empyema thoracis. Factors influencing morbidity and mortality. | journal=Chest | year= 1991 | volume= 99 | issue= 5 | pages= 1162-5 | pmid=2019172 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2019172 }}</ref><ref name="pmid7634854">{{cite journal| author=Light RW| title=A new classification of parapneumonic effusions and empyema. | journal=Chest | year= 1995 | volume= 108 | issue= 2 | pages= 299-301 | pmid=7634854 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7634854 }}</ref><ref name="pmid11035692">{{cite journal| author=Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B et al.| title=Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. | journal=Chest | year= 2000 | volume= 118 | issue= 4 | pages= 1158-71 | pmid=11035692 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11035692 }}</ref> Pharmacologic therapies for acute empyema include either [[Ceftriaxone]], [[Nafcillin]] or [[Oxacillin]], [[Vancomycin]] or [[Linezolid]], or [[TMP-SMX]]. The preferred regimen for subacute and chronic empyema is a combination of [[Clindamycin]] and [[Ceftriaxone]]. | |||
==Medical Therapy== | ==Medical Therapy== | ||
Definitive treatment for empyema entails drainage of the infected pleural fluid. A [[chest tube]] may be inserted, often using ultrasound guidance. [[Intravenous]] [[antibiotic]]s are given. If this is insufficient, surgical [[debridement]] of the pleural space may be required. | Definitive treatment for empyema entails drainage of the infected pleural fluid. A [[chest tube]] may be inserted, often using ultrasound guidance. [[Intravenous]] [[antibiotic]]s are given. If this is insufficient, surgical [[debridement]] of the pleural space may be required. |
Revision as of 18:10, 16 January 2017
Pleural empyema Microchapters |
Diagnosis |
Treatment |
Case Studies |
Pleural empyema medical therapy On the Web |
American Roentgen Ray Society Images of Pleural empyema medical therapy |
Risk calculators and risk factors for Pleural empyema medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Overview
The mainstay of therapy for empyema includes:[1] controlling the infectious focus, drainage of fluid and pus, re-expansion of the lung. This involes the use of antimicrobial agents, thrombolytics,[2][3] and drainage of the pleural space.[4][5][6] Pharmacologic therapies for acute empyema include either Ceftriaxone, Nafcillin or Oxacillin, Vancomycin or Linezolid, or TMP-SMX. The preferred regimen for subacute and chronic empyema is a combination of Clindamycin and Ceftriaxone.
Medical Therapy
Definitive treatment for empyema entails drainage of the infected pleural fluid. A chest tube may be inserted, often using ultrasound guidance. Intravenous antibiotics are given. If this is insufficient, surgical debridement of the pleural space may be required.
Antibiotic Therapy
Following are the guidelines to treat Pleural empyema .[7][8]
▸ Click on the following categories to expand treatment regimens.
Pleural Empyema ▸ Neonates ▸ Infants/Children ▸ Adult |
|
|
|
Surgical management
- Antibiotic treatment should be continued for atleast 4 to 6 weeks. Sometimes it may be needed for a longer time. A CT and chest tube output should be used to confirm a complete fluid drainage with no residual locules present.
- Other modes of draining pleural fluid are tube thoracostomy, video-assisted thoracoscopic surgery (VATS), open decortication, and open thoracostomy.
Tube thoracostomy
- Least invasive
- Preferred for unilocuated effusions and free-flowing fluid.
- For solitary lesions a CT scan or ultrasound is used to guide the tube.
- For lesions more than one multiple small catheters are used to drain.
- When draining empyema fluid, thoracostomy tubes are typically placed using either an ultrasound or CT-guided approach. When multiple loculations are present, we typically place small-bore catheters, as multiple tubes may be needed to drain the multiloculated pleural space.
- A trial showed no difference between different sizes of thoracostomy tube. Smaller tubes were preferred due to decreased pain.[9][10]
- British thoracic society recommends flushing the tube every 6 hrs to remain patent.[11]. Smaller tubes are more prone to failure due to blockage.[12]. Chest tubes are placed atleast till the cavity closes or drainage falls below 50 ml/day.
- Confirm correct placement of the tube using CT scans and checking drainage .
Fibrinolytic agents
- Empyema drainage is facilitated by the use of intrapleural use of fibrinolytic agents .[13][14][15][16][17][18]
- Surgical thoracotomy with decortication is preferred to thorascopic debridement in patients who have more pleural thickness , larger cavity and adhesions.[19][20][21]
Post surgical complications
An empyema forming in a space created by surgery with or without a fistula between bronchus and pleura should be treated carefully.[22]Available treatment options are :
- Irrigation with antibiotic
- Filling up the space with pedicles of muscles
- Closing the fistula surgically
Open Thoracostomy
An incision is made through the chest wall to aid drainage at the inferior border of the cavity . A chest tube is inserted and left to drain the remaining cavity . This process is time consuming and requires at least 2-3 months. However a few side effects of anesthesia and chest tube infection still remain.
References
- ↑ Reichert M, Hecker M, Witte B, Bodner J, Padberg W, Weigand MA; et al. (2016). "Stage-directed therapy of pleural empyema". Langenbecks Arch Surg. doi:10.1007/s00423-016-1498-9. PMID 27815709.
- ↑ Porcel JM, Valencia H, Bielsa S (2016). "Manual Intrapleural Saline Flushing Plus Urokinase: A Potentially Useful Therapy for Complicated Parapneumonic Effusions and Empyemas". Lung. doi:10.1007/s00408-016-9964-2. PMID 27866276.
- ↑ Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C; et al. (2011). "Intrapleural use of tissue plasminogen activator and DNase in pleural infection". N Engl J Med. 365 (6): 518–26. doi:10.1056/NEJMoa1012740. PMID 21830966. Review in: Ann Intern Med. 2011 Dec 20;155(12):JC6-9
- ↑ Ashbaugh DG (1991). "Empyema thoracis. Factors influencing morbidity and mortality". Chest. 99 (5): 1162–5. PMID 2019172.
- ↑ Light RW (1995). "A new classification of parapneumonic effusions and empyema". Chest. 108 (2): 299–301. PMID 7634854.
- ↑ Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B; et al. (2000). "Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline". Chest. 118 (4): 1158–71. PMID 11035692.
- ↑ Bradley, JS.; Byington, CL.; Shah, SS.; Alverson, B.; Carter, ER.; Harrison, C.; Kaplan, SL.; Mace, SE.; McCracken, GH. (2011). "The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America". Clin Infect Dis. 53 (7): e25–76. doi:10.1093/cid/cir531. PMID 21880587. Unknown parameter
|month=
ignored (help) - ↑ Rahman, NM.; Maskell, NA.; West, A.; Teoh, R.; Arnold, A.; Mackinlay, C.; Peckham, D.; Davies, CW.; Ali, N. (2011). "Intrapleural use of tissue plasminogen activator and DNase in pleural infection". N Engl J Med. 365 (6): 518–26. doi:10.1056/NEJMoa1012740. PMID 21830966. Unknown parameter
|month=
ignored (help) - ↑ Maskell, NA.; Davies, CW.; Nunn, AJ.; Hedley, EL.; Gleeson, FV.; Miller, R.; Gabe, R.; Rees, GL.; Peto, TE. (2005). "U.K. Controlled trial of intrapleural streptokinase for pleural infection". N Engl J Med. 352 (9): 865–74. doi:10.1056/NEJMoa042473. PMID 15745977. Unknown parameter
|month=
ignored (help) - ↑ Rahman, NM.; Maskell, NA.; Davies, CW.; Hedley, EL.; Nunn, AJ.; Gleeson, FV.; Davies, RJ. (2010). "The relationship between chest tube size and clinical outcome in pleural infection". Chest. 137 (3): 536–43. doi:10.1378/chest.09-1044. PMID 19820073. Unknown parameter
|month=
ignored (help) - ↑ Davies, CW.; Gleeson, FV.; Davies, RJ. (2003). "BTS guidelines for the management of pleural infection". Thorax. 58 Suppl 2: ii18–28. PMID 12728147. Unknown parameter
|month=
ignored (help) - ↑ Horsley, A.; Jones, L.; White, J.; Henry, M. (2006). "Efficacy and complications of small-bore, wire-guided chest drains". Chest. 130 (6): 1857–63. doi:10.1378/chest.130.6.1857. PMID 17167009. Unknown parameter
|month=
ignored (help) - ↑ Jerjes-Sánchez, C.; Ramirez-Rivera, A.; Elizalde, JJ.; Delgado, R.; Cicero, R.; Ibarra-Perez, C.; Arroliga, AC.; Padua, A.; Portales, A. (1996). "Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial". Chest. 109 (6): 1514–9. PMID 8769503. Unknown parameter
|month=
ignored (help) - ↑ Temes, RT.; Follis, F.; Kessler, RM.; Pett, SB.; Wernly, JA. (1996). "Intrapleural fibrinolytics in management of empyema thoracis". Chest. 110 (1): 102–6. PMID 8681611. Unknown parameter
|month=
ignored (help) - ↑ Davies, RJ.; Traill, ZC.; Gleeson, FV. (1997). "Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection". Thorax. 52 (5): 416–21. PMID 9176531. Unknown parameter
|month=
ignored (help) - ↑ Bouros, D.; Schiza, S.; Tzanakis, N.; Chalkiadakis, G.; Drositis, J.; Siafakas, N. (1999). "Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study". Am J Respir Crit Care Med. 159 (1): 37–42. doi:10.1164/ajrccm.159.1.9803094. PMID 9872815. Unknown parameter
|month=
ignored (help) - ↑ Diacon, AH.; Theron, J.; Schuurmans, MM.; Van de Wal, BW.; Bolliger, CT. (2004). "Intrapleural streptokinase for empyema and complicated parapneumonic effusions". Am J Respir Crit Care Med. 170 (1): 49–53. doi:10.1164/rccm.200312-1740OC. PMID 15044206. Unknown parameter
|month=
ignored (help) - ↑ Thomson, AH.; Hull, J.; Kumar, MR.; Wallis, C.; Balfour Lynn, IM. (2002). "Randomised trial of intrapleural urokinase in the treatment of childhood empyema". Thorax. 57 (4): 343–7. PMID 11923554. Unknown parameter
|month=
ignored (help) - ↑ Thommi, G.; Nair, CK.; Aronow, WS.; Shehan, C.; Meyers, P.; McLeay, M. "Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema". Am J Ther. 14 (4): 341–5. doi:10.1097/01.mjt.0000208275.88120.d1. PMID 17667208.
- ↑ Tuncozgur, B.; Ustunsoy, H.; Sivrikoz, MC.; Dikensoy, O.; Topal, M.; Sanli, M.; Elbeyli, L. (2001). "Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial". Int J Clin Pract. 55 (10): 658–60. PMID 11777287. Unknown parameter
|month=
ignored (help) - ↑ Tokuda, Y.; Matsushima, D.; Stein, GH.; Miyagi, S. (2006). "Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis". Chest. 129 (3): 783–90. doi:10.1378/chest.129.3.783. PMID 16537882. Unknown parameter
|month=
ignored (help) - ↑ CLAGETT, OT.; GERACI, JE. (1963). "A procedure for the management of postpneumonectomy empyema". J Thorac Cardiovasc Surg. 45: 141–5. PMID 14021469. Unknown parameter
|month=
ignored (help)